Efficacy of glucantime in the treatment of old world cutaneous leishmaniasis

International Journal of Dermatology

Volumn 48, Issue 7, 2009, Pages 758-762

  Firdous, Rukhsana ^a   Yasinzai, Masoom ^a   Ranja, Khalid ^a  

^a UNIVERSITY OF BALOCHISTAN   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

MEGLUMINE ANTIMONATE;

ADULT; ANOREXIA; ARTHRALGIA; ARTICLE; BODY TEMPERATURE; CARDIOVASCULAR DISEASE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG TREATMENT FAILURE; ENDEMIC DISEASE; EVENING DOSAGE; HUMAN; HUMAN TISSUE; LEISHMANIA MAJOR; MAJOR CLINICAL STUDY; MILITARY DEPLOYMENT; MORNING DOSAGE; RECOMMENDED DRUG DOSE; SIDE EFFECT; SKIN BIOPSY; SKIN LEISHMANIASIS; SOLDIER; TREATMENT DURATION; VERTIGO;

ADULT; ANIMALS; ANTIPROTOZOAL AGENTS; ENDEMIC DISEASES; HUMANS; INSECT BITES AND STINGS; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MALE; MEGLUMINE; MILITARY PERSONNEL; ORGANOMETALLIC COMPOUNDS; PAKISTAN; PSYCHODIDAE; YOUNG ADULT;

EID: 67649230517     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2009.04072.x     Document Type: Article

References (13)

1. Alraghi AA. Cutaneous leishmaniasis of the Old World. Skin Ther Lett 2003; 8: 1-4.
2. McHugh CP. Arthropods: Vectors of disease agents. Lab Med 1994; 25: 429-437.
3. Yasinzai M, Iqbal J. Kakar JK, et al. Leishmaniasis in Pakistan: revisited. J Coll Physicians Surg Pak 1996; 6: 70-75.
4. Kakarsulemankhel JK Cutaneous leishmaniasis in south west Pakistan: A preliminary study. Tarkiye Parazitoloji Degisis 2004; 28: 5-11.
5. Herwaldt BL, Stokes SL, Juranek DD. American cutaneous leishmaniasis in U.S. travelers. Ann Intern Med 1993; 118: 779-784.
6. Sundar S, More DK, Singh MK, et al. Failure of pentavalent antimony in visceral leishmaniasis in India: Report from the center of the Indian epidemic. Clin Infect Dis 2000; 31: 1104-1107.
7. Ouellette M, Drummelsmith J, Papadopoulou B. Leishmaniasis: Drugs in the clinic, resistance and new developments. Drug Resist Update 2004; 7: 257-266.
8. Alvar J, Croft S, Olliaro P, Chemotherapy in the treatment and control of leishmaniasis. Adv Parasitol 2006; 61: 224-261.
9. Evans D, ed. World Health Organization Handbook of Isolation, Characterization and Cryopreservation of Leishmania. Town: UNDP/World Bank/WHO, 1989: 1-45.
10. Rab MA, Azmi FA, Iqbal J, et al. Cutaneous leishmaniasis in Balochistan: reservoir host and sand fly vector in Uthal, Lasbella. J Pak Med Assoc 1986; 36: 134-138.
11. World Health Organization (WHO). Control of the Leishmaniases. Report of a WHO Expert Committee, WHO Technical Report Series 793. Geneva: World Health Organization, 1990.
12. Soto J, Toledo J, Vega J, et al. Short report: Efficacy of pentavalent antimony for treatment of Colombian cutaneous leishmaniasis. Am J Trop Med Hyg 2005; 72: 421-422.
13. Palacios R, Osorio IE, Grajales IF, et al. Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimoniate for cutaneous leishmaniasis due to Leishmania viannia species. Am J Trop Med Hyg 2001; 64: 187-193.